{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:34:34Z","timestamp":1792748074547,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.bone.2010.06.028","type":"journal-article","created":{"date-parts":[[2010,7,6]],"date-time":"2010-07-06T08:41:12Z","timestamp":1278405672000},"page":"152-159","source":"Crossref","is-referenced-by-count":27,"title":["Neuroblastoma and bone metastases: Clinical significance and prognostic value of Dickkopf 1 plasma levels"],"prefix":"10.1016","volume":"48","author":[{"given":"Donatella","family":"Granchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Valeria","family":"Corrias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Garaventa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena Rubina","family":"Bagl\u00eco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Cangemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Carlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Paolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Giunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2010.06.028_bb0005","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1017\/S1462399408000616","article-title":"Molecular mechanisms and treatment of bone metastasis","volume":"10","author":"Clines","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.bone.2010.06.028_bb0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pcl.2007.10.014","article-title":"Neuroblastoma: biology, prognosis, and treatment","volume":"55","author":"Park","year":"2008","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.bone.2010.06.028_bb0015","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1200\/JCO.1993.11.8.1466","article-title":"Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment","volume":"11","author":"Brodeur","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bone.2010.06.028_bb0020","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1634\/theoncologist.8-3-278","article-title":"Advances in the diagnosis and treatment of neuroblastoma","volume":"8","author":"Weinstein","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.bone.2010.06.028_bb0025","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.1998.16.3.953","article-title":"Multivariate analysis of risk factors in Stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry","volume":"16","author":"Ladenstein","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bone.2010.06.028_bb0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bmt.1705929","article-title":"Stem cell transplantation for neuroblastoma","volume":"41","author":"Fish","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bone.2010.06.028_bb0035","first-page":"1637","article-title":"Receptor activator of nuclear factor kB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma","volume":"61","author":"Michigami","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2010.06.028_bb0040","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ijc.20308","article-title":"In vitro blockade of receptor activator of nuclear factor-kB ligand prevents osteoclastogenesis induced by neuroblastoma cells","volume":"111","author":"Granchi","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bone.2010.06.028_bb0045","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1158\/0008-5472.CAN-04-2853","article-title":"Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells","volume":"65","author":"Sohara","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2010.06.028_bb0050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2005.01.059","article-title":"Mechanisms of bone invasion and metastasis in human neuroblastoma","volume":"228","author":"Sohara","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bone.2010.06.028_bb0055","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10555-006-9028-9","article-title":"Mechanisms of invasion and metastasis in human neuroblastoma","volume":"25","author":"Ara","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.bone.2010.06.028_bb0060","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ijc.21783","article-title":"Plasma levels of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in patients with neuroblastoma","volume":"119","author":"Granchi","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bone.2010.06.028_bb0065","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/0008-5472.CAN-08-0613","article-title":"Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells","volume":"69","author":"Ara","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2010.06.028_bb0070","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/ijc.23654","article-title":"Paracrine inhibition of osteoblast differentiation induced by neuroblastoma cells","volume":"123","author":"Granchi","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bone.2010.06.028_bb0075","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/jcb.22020","article-title":"Wnt pathway, an essential role in bone regeneration","volume":"106","author":"Chen","year":"2009","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2010.06.028_bb0080","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1196\/annals.1334.010","article-title":"How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow","volume":"1049","author":"Gregory","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.bone.2010.06.028_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11154-006-9002-4","article-title":"Wnt signaling and osteoblastogenesis","volume":"7","author":"Bodine","year":"2006","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.bone.2010.06.028_bb0090","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bone.2007.12.006","article-title":"Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma","volume":"42","author":"Qiang","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.06.028_bb0095","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/sj.bjc.6603959","article-title":"Increased Dickkopf-1 expression in breast cancer bone metastases","volume":"97","author":"Voorzanger-Rousselot","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bone.2010.06.028_bb0100","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.1158\/0008-5472.CAN-05-1317","article-title":"Prostate cancer cells promote osteoblastic bone metastases through Wnts","volume":"65","author":"Hall","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2010.06.028_bb0105","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood-2008-03-145169","article-title":"The role of Dickkopf-1 in bone development, homeostasis, and disease","volume":"113","author":"Pinzone","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bone.2010.06.028_bb0110","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1600-0609.2008.01065.x","article-title":"Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma","volume":"80","author":"Kaiser","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bone.2010.06.028_bb0115","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00223-009-9225-y","article-title":"Assessment of circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases","volume":"84","author":"Voorzanger-Rousselot","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2010.06.028_bb0120","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1373\/clinchem.2009.125641","article-title":"Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer","volume":"55","author":"Le Sheng","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.bone.2010.06.028_bb0125","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3324\/haematol.2008.000893","article-title":"Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration","volume":"94","author":"Voskaridou","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.bone.2010.06.028_bb0130","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.clinbiochem.2009.04.007","article-title":"Increased circulating Dickkopf-1 in Paget's disease of bone","volume":"42","author":"Marshall","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1016\/j.bone.2010.06.028_bb0135","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1161\/ATVBAHA.109.189761","article-title":"Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis","volume":"29","author":"Ueland","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.bone.2010.06.028_bb0140","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/IGC.0b013e31819d8b2d","article-title":"Clinical significance of serum DKK-1 in patients with gynecological cancer","volume":"19","author":"Jiang","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bone.2010.06.028_bb0145","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.1995.13.4.884","article-title":"Localized resectable neuroblastoma: results of the second study of the Italian Cooperative Group for Neuroblastoma","volume":"13","author":"De Bernardi","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bone.2010.06.028_bb0150","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/annonc\/mdf165","article-title":"Italian Cooperative Group for Neuroblastoma: localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors","volume":"13","author":"Garaventa","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bone.2010.06.028_bb0155","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1200\/JCO.2003.05.191","article-title":"Italian co-operative group for neuroblastoma: disseminated neuroblastoma in children older than one year at diagnosis: Comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma","volume":"21","author":"De Bernardi","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bone.2010.06.028_bb0160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.0.CO;2-Y","article-title":"Terminology and morphologic criteria of neuroblastic tumors","volume":"86","author":"Shimada","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.bone.2010.06.028_bb0165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cancergencyto.2006.10.005","article-title":"Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma","volume":"172","author":"Altungoz","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.bone.2010.06.028_bb0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/bmj.326.7379.41","article-title":"Standards for reporting of diagnostic accuracy steering group. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative","volume":"326","author":"Bossuyt","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.bone.2010.06.028_bb0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/bmj.323.7305.157","article-title":"Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests","volume":"323","author":"Deeks","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.bone.2010.06.028_bb0180","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/sj.onc.1203503","article-title":"Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53","volume":"19","author":"Wang","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bone.2010.06.028_bb0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/carcin\/bgg190","article-title":"A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation","volume":"25","author":"Mikheev","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bone.2010.06.028_bb0190","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.bjc.6603579","article-title":"The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumors and in some common cancer types","volume":"96","author":"Forget","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bone.2010.06.028_bb0195","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1158\/0008-5472.CAN-06-3369","article-title":"Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas","volume":"67","author":"Yamabuki","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2010.06.028_bb0200","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2141.2009.07587.x","article-title":"Platelet is a major contributor to circulating levels of Dickkopf-1: clinical implications in patients with multiple myeloma","volume":"145","author":"Voorzanger-Rousselot","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bone.2010.06.028_bb0205","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.canlet.2007.06.011","article-title":"Dickkopf-1 is down-regulated by MYCN and inhibits neuroblastoma cell proliferation","volume":"256","author":"Koppen","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bone.2010.06.028_bb0210","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/sj.onc.1210769","article-title":"Deregulated Wnt\/beta-catenin program in high-risk neuroblastomas without MYCN amplification","volume":"27","author":"Liu","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bone.2010.06.028_bb0215","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/onc.2009.80","article-title":"The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt\/beta-catenin pathway","volume":"28","author":"Flahaut","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.bone.2010.06.028_bb0220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.biopha.2009.09.005","article-title":"The Wnt signaling pathway regulates Nalm-16 B-cell precursor acute lymphoblastic leukemic cell line survival and etoposide resistance","volume":"64","author":"Thiago","year":"2010","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bone.2010.06.028_bb0225","doi-asserted-by":"crossref","first-page":"83.1","DOI":"10.1186\/gm83","article-title":"Networking of differentially expressed genes in human cancer cells resistant to methotrexate","volume":"1","author":"Selga","year":"2009","journal-title":"Genome Med"},{"key":"10.1016\/j.bone.2010.06.028_bb0230","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1200\/JCO.2004.12.185","article-title":"Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015)","volume":"22","author":"Blaney","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bone.2010.06.028_bb0235","first-page":"439","article-title":"Anti-cancer effects of bortezomib against chemoresistant neuroblastoma cell lines in vitro and in vivo","volume":"28","author":"Michaelis","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bone.2010.06.028_bb0240","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/jnci\/djj309","article-title":"Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis","volume":"98","author":"Brignole","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bone.2010.06.028_bb0245","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.surg.2007.04.012","article-title":"Bortezomib inhibits angiogenesis and reduces tumor burden in a murine model of neuroblastoma","volume":"142","author":"Hamner","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.bone.2010.06.028_bb0250","unstructured":"A study to assess BHQ880 in combination with zoledronic acid in relapsed or refractory myeloma patients. August, 2008. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00741377."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328210013426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328210013426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:52:32Z","timestamp":1559245952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328210013426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S8756328210013426"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2010.06.028","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}